Scientific Advisory Board
Renowned leaders in academia and biotechnology are bringing valuable insights and acclaimed expertise to RCI.
Perry Hackett, PhD
Dr. Perry Hackett is a co-founder of Recombinetics and serves as Chair of its Scientific Advisory Board. He is a co-founder of gene therapy company, Discovery Genomics, where he previously served as Chief Scientific Officer and Chairman. He is also a professor and research scientist in the University of Minnesota’s department of Genetics, Cell Biology, and Development and co-founder of the Center for Genome Engineering. Hackett has a degree in Physics from Stanford University, a Ph.D. in Biophysics and Genetics from the University of Colorado, and did postdoctoral training at the Max Planck Institute for Cell Biology in Germany and at the University of California in San Francisco.
Jef Boeke, PhD
Dr. Boeke is an expert in yeast genetics including transposon dynamics and assembling artificial chromosomes. He is the founding director of the Institute for Systems Genetics and a professor in the Department of Biochemistry and Molecular Pharmacology at the NYU Langone Medical Center. Dr. Boeke is a member of the American Academy of Arts and Sciences and the National Academy of Sciences.
Ina Dobrinski, DVM, PhD
Dr. Dobrinski is a preeminent researcher in mammalian germ line stem-cell biology. She is Head of the Department of Comparative Biology and Experimental Medicine at the University of Calgary. Dr. Dobrinski is board certified by the American College of Theriogenologists (Animal Reproduction).
Dana Carroll, PhD
Dr. Carroll is widely recognized as the father of gene editing, and the inventor of zinc finger nucleases. Dr. Carroll is a distinguished professor in biochemistry at the University of Utah School of Medicine and is a member of the Nuclear Control of Cell Growth and Differentiation Program at the Huntsman Cancer Institute in Salt Lake City. He is an awardee of the Novitski Prize from the Genetics Society of America for establishing the field of genome editing.
George Church, PhD
Dr. Church is a leader in the fields of computational genetics, genomics, bioinformatics, systems biology, bioengineering, and technology development. He is a professor of genetics at Harvard Medical School and a professor of health sciences and technology at Harvard and MIT and a founding member of the Wyss Institute for Biologically Inspired Engineering. Dr. Church is director of the U.S. Department of Energy Technology Center, director of the National Institutes of Health Center of Excellence in Genomic Science and director of the Personal Genome Project. He has co-founded nine biotech companies and is a member of the National Academy of Sciences and the National Academy of Engineering.
Stephen C. Ekker, PhD
Dr. Ekker is a pioneer in the use of diverse genome engineering tools in zebrafish and other organisms. He is a professor of biochemistry and molecular biology at the Mayo Clinic and associate director of the Clinical and Translational Sciences Ph.D. program. Dr. Ekker is president of the Zebrafish Disease Models Society and editor-in-chief of the Zebrafish journal. He is co-founder of three biotech companies and one non-profit, and the founding director of the Center for Genome Engineering at the University of Minnesota.
Jerry Taylor, PhD
Dr. Taylor, is one of the top scholars and influencers in the field of agricultural genomics. He is best known for establishing ways to use DNA-based genomic improvement in livestock and crops. Dr. Taylor is a professor of genetics and animal sciences at the University of Missouri and the Wurdack Chair of Animal Genomics. He is a founder of GenomicFX, Inc., and fellow of the American Association for the Advancement of Science.
Bruce Whitelaw, PhD
Dr. Whitelaw is a pioneer in the development of genetically engineered and genome edited livestock for biomedical and agricultural applications. He is head of the Division of Developmental Biology at the Roslin Institute and a professor of animal biotechnology at the Royal (Dick) School of Veterinary Studies in Edinburgh, Scotland. Dr. Whitelaw is the editor of Transgenic Research, and serves on several scientific advisory boards.